Healthcare

Cassidy Bio

An AI genomic foundation model that predicts how gene-editing therapies will behave

Visit Cassidy Bio
1 viewsPricing · PaidRising
The Falcoscan Intel Panel/Cassidy Bio · Healthcare
Live market data
Opportunity
84
Strong/ 100
Saturation
11
Open/ 100
Wrapper Risk
9
Open/ 100
Signal
Rising
Market trend
The Brief

What Cassidy Bio does

Cassidy Bio builds an AI-driven genomic foundation model that predicts efficacy, safety and repair outcomes for gene-editing therapies across diverse patient genomes, aiming to compress years of trial-and-error lab work into days for therapeutic developers. It offers its predictive platform to biotech and pharma partners developing gene-editing treatments rather than direct consumers. The company was co-founded by CEO Rom Kshuk, a serial biotech entrepreneur, CRISPR scientist Ayal Hendel and AI researcher Yaniv Shmueli, and seeded in part through AstraZeneca and Merck KGaA's venture track at AION Labs.

Builder’s Brief

Cassidy Bio is a healthcare tool on Falcoscan. An AI genomic foundation model that predicts how gene-editing therapies will behave. Falcoscan rates Cassidy Bio with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Cassidy Bio is founded in 2025, currently at Seed stage. Pricing: Paid.

Market position · Healthcare

How Cassidy Bio compares in Healthcare

Cassidy Bio's opportunity score of 84 ranks #51 of 192 live Healthcare tools on Falcoscan, 1.4 points above the category average of 82.6. Its saturation score is 11/100, against a category average of 11. 86 of the 192 live Healthcare tools carry a hot signal, and Falcoscan has recorded 8 shutdowns in the category.

Cassidy Bio compared with top-rated Healthcare tools
ProductOpportunitySaturationPricingSignal
Cassidy Bio8411PaidRising
DeepMind AlphaFold886FreeHot
Nuance DAX Copilot9012PaidHot
Viz.ai AI Stroke Response906PaidHot
Tempus AI Diagnostics886PaidHot
Viz.ai Stroke AI888PaidHot
What it ships with

Capabilities & who uses it

The capabilities Cassidy Bio exposes to builders and the verticals it currently serves.

AI Capabilities
Genomic Outcome PredictionGuide Rna DesignDelivery Strategy Optimization
Industry Verticals
BiotechnologyPharmaceuticalsHealthcare
Tagged

Cassidy Bio shows up when builders search for these

gene-editinggenomic-foundation-modelbiotech-aicrisprdrug-discovery
Similar tools · Healthcare

Alternatives to Cassidy Bio

The top-rated live healthcare tools tracked on Falcoscan, ranked by Falcoscan rating within the category.

See the Healthcare market
Healthcare
DeepMind AlphaFold

AI protein structure prediction for drug discovery

★ 4.9Opp 88
Free
Healthcare
Nuance DAX Copilot

AI clinical documentation assistant for physicians

★ 4.8Opp 90
Paid
Healthcare
Viz.ai AI Stroke Response

AI stroke detection and care coordination platform

★ 4.8Opp 90
Paid
Healthcare
Tempus AI Diagnostics

AI liquid biopsy analysis for early cancer detection

★ 4.8Opp 88
Paid
Healthcare
Viz.ai Stroke AI

AI triage and coordination platform for stroke care

★ 4.8Opp 88
Paid
Healthcare
Anterior AI Insurance

AI prior authorization automation for health insurance

★ 4.7Opp 88
Paid
Questions

Cassidy Bio: common questions

Is Cassidy Bio free?

No. Cassidy Bio is a paid product.

What are the best alternatives to Cassidy Bio?

The top-rated live Healthcare tools on Falcoscan, other than Cassidy Bio, are DeepMind AlphaFold, Nuance DAX Copilot, Viz.ai AI Stroke Response, Tempus AI Diagnostics, and Viz.ai Stroke AI.

Is Cassidy Bio still operating?

Yes. Falcoscan's operating checks list Cassidy Bio as active.

Where is Cassidy Bio based?

Cassidy Bio is headquartered in Tel Aviv, Israel.

Does Cassidy Bio have an API?

Falcoscan's records show no public API for Cassidy Bio.

Who is Cassidy Bio for?

Cassidy Bio is built for biotech companies, pharma r d teams, and gene therapy developers.

Back to Browse